Literature DB >> 7026093

Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders.

R E Callard, C M Smith, C Worman, D Linch, J C Cawley, P C Beverley.   

Abstract

We have studied two patients, one with red cell aplasia and the other with neutropenia. Both showed lymphocytosis. In both cases, 90-100% of E rosetting cells were T cells as defined by the monoclonal antibodies UCHT1 and OKT3. The majority of these cells also carried the OKT8 suppressor/cytotoxic marker and were HLA-DR- and Fc gamma R-positive. In spite of the similarity of this phenotype to that reported for suppressor cells, these cells failed to suppress pokeweed mitogen-induced polyclonal Ig synthesis. Cells from both patients also failed to respond significantly to Con A and PHA. They were, however, unable to suppress the Con A responses of normal donors although cells from one patient were able to suppress completely a normal PHA response. These results demonstrate the existence of a genuine subset of T cells with Fc gamma receptors but suggest that not all such cells have typical suppressor function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026093      PMCID: PMC1537177     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells.

Authors:  M Ferrarini; L Moretta; R Abrile; M L Durante
Journal:  Eur J Immunol       Date:  1975-01       Impact factor: 5.532

2.  Different Ly antigen phenotypes of in vitro induced helper and suppressor cells.

Authors:  M Feldmann; P C Beverley; M Dunkley; S Kontiainen
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

3.  Separation of suppressor and killer T cells by surgace phenotype.

Authors:  P C Beverley; J Woody; M Dunkley; M Feldmann; I McKenzie
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

4.  Expression of a receptor for IgM by human T cells in vitro.

Authors:  L Moretta; M Ferrarini; M L Durante; M C Mingari
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

5.  New evidence relating to the nature and origin of the hairy cell of leukaemic reticuloendotheliosis.

Authors:  G F Burns; J C Cawley; C R Barker; A H Goldstone; F G Hayhoe
Journal:  Br J Haematol       Date:  1977-05       Impact factor: 6.998

6.  Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

7.  Fc-receptor heterogeneity of human suppressor T cells.

Authors:  A R Hayward; L Layward; P M Lydyard; L Moretta; M Dagg; A R Lawton
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

8.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

9.  Opsonic adherence of sensitized ox red cells to human lymphocytes as measured by rosette formation.

Authors:  T Hallberg; B W Gurner; R R Coombs
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  23 in total

1.  Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: proof of monoclonality of the LGL-population, but benign clinical course.

Authors:  S Serke; A Neubauer; D Huhn
Journal:  Klin Wochenschr       Date:  1989-06-01

Review 2.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

3.  A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells.

Authors:  L Al-Sakkaf; P Pozzilli; M Sensi; W L Irving; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

4.  The fine structure of normal lymphocyte subpopulations--a study with monoclonal antibodies and the immunogold technique.

Authors:  E Matutes; D Catovsky
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

5.  Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations.

Authors:  M J Raftery; L W Poulter; G Janossy; P Sweny; O N Fernando; J F Moorhead
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

6.  Classification of patients with T-cell chronic lymphocytic leukemia and expansions of granular lymphocytes: heterogeneity of Italian cases by a multiparameter analysis.

Authors:  F Pandolfi; F Mandelli; G Semenzato; A Ranucci; F Aiuti
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

7.  Proliferation of T gamma-lymphocytes in two patients: clinical features and functional properties of the proliferating cells.

Authors:  G Schlimok; E Thiel; E P Rieber; D Huhn; H Feucht; D Renner; G Riethmüller
Journal:  Klin Wochenschr       Date:  1982-02-01

8.  Immunological parameters in the aged and in Alzheimer's disease.

Authors:  S M Macdonald; A H Goldstone; J E Morris; A N Exton-Smith; R E Callard
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

9.  A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function.

Authors:  A Landay; M C Poon; L T Clement; C E Grossi
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.

Authors:  R E Callard; T M Ewing; R M Fox
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.